Moonlake Immunotherapeutics Ownership
$11.41
0.52%
Nasdaq, Oct 02, 04:01 pm EDT.
Closed.
Industry
Moonlake Immunotherapeutics Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
BVF Partners L.P.
|
16.001m | 19.14% | -3.750m | Mar 31 2026 |
| 2 |
Deep Track Capital LP
|
6.409m | 7.67% | +1.799m | Mar 31 2026 |
| 3 |
Cormorant Asset Management, LP
INSIDER
|
4.480m | 5.36% | +125.000k | Mar 31 2026 |
| 4 |
Janus Henderson Investors
|
3.452m | 4.13% | +1.356m | Mar 31 2026 |
| 5 |
Reich (Kristian)
|
3.010m | 3.60% | +48.978k | Apr 01 2026 |
|
1
BVF Partners L.P.
|
19.14%
16.001m
|
|
2
Deep Track Capital LP
|
7.67%
6.409m
|
|
3
Cormorant Asset Management, LP
INSIDER
|
5.36%
4.480m
|
|
4
Janus Henderson Investors
|
4.13%
3.452m
|
|
5
Reich (Kristian)
|
3.60%
3.010m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 39.89% of Moonlake Immunotherapeutics, with BVF Partners L.P. the biggest at 19.14%, followed by Deep Track Capital LP (7.67%) and Cormorant Asset Management, LP (5.36%). |
Recent Moonlake Immunotherapeutics Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 05 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 02 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 28 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 23 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 17 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 10 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 05 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 02 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 28 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 23 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 17 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 10 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
